Insider Trading
Track Major Insider Updates On X/Twitter
NVCR Stock Insider Trading Activity
Corporate insiders are required to disclose purchases or sales of their own stock within two business days of when they occur. Using these disclosures, we collect data on NVCR stock insider trading activity, which can give hints on whether NovoCure Ltd executives are bullish or bearish on their own company.
Recent insider purchases and sales - NVCR
| Name / Title | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
|
Weinberg Uri
Chief Innovation Officer
|
Sale | 4326 | Feb 28, 2025 | March 3, 2025, 5:28 p.m. |
|
Weinberg Uri
Chief Innovation Officer
|
Sale | 311 | Feb 28, 2025 | March 3, 2025, 5:28 p.m. |
|
Leupin Nicolas
Chief Medical Officer
|
Sale | 161 | Feb 27, 2025 | March 3, 2025, 5:28 p.m. |
|
Leupin Nicolas
Chief Medical Officer
|
Sale | 830 | Feb 27, 2025 | March 3, 2025, 5:28 p.m. |
|
Puri Michal Nath
Chief Human Resources Officer
|
Sale | 225 | Feb 27, 2025 | March 3, 2025, 5:27 p.m. |
|
Puri Michal Nath
Chief Human Resources Officer
|
Sale | 1162 | Feb 27, 2025 | March 3, 2025, 5:27 p.m. |
|
Leonard Frank X
EVP, Pres., Novocure Oncology
|
Sale | 2770 | Feb 28, 2025 | March 3, 2025, 5:27 p.m. |
|
Leonard Frank X
EVP, Pres., Novocure Oncology
|
Sale | 1989 | Feb 27, 2025 | March 3, 2025, 5:27 p.m. |
|
Leonard Frank X
EVP, Pres., Novocure Oncology
|
Sale | 10277 | Feb 27, 2025 | March 3, 2025, 5:27 p.m. |
|
Cordova Ashley
Chief Executive Officer
|
Sale | 9345 | Feb 27, 2025 | March 3, 2025, 5:26 p.m. |
|
Cordova Ashley
Chief Executive Officer
|
Sale | 2341 | Feb 28, 2025 | March 3, 2025, 5:26 p.m. |
|
Cordova Ashley
Chief Executive Officer
|
Sale | 1808 | Feb 27, 2025 | March 3, 2025, 5:26 p.m. |
|
Paravasthu Mukund
Chief Operating Officer
|
Sale | 1379 | Feb 27, 2025 | March 3, 2025, 5:26 p.m. |
|
Paravasthu Mukund
Chief Operating Officer
|
Sale | 267 | Feb 27, 2025 | March 3, 2025, 5:26 p.m. |
|
Paravasthu Mukund
Chief Operating Officer
|
Sale | 368 | Feb 28, 2025 | March 3, 2025, 5:26 p.m. |
|
Paravasthu Mukund
Chief Operating Officer
|
Sale | 2160 | Jan 11, 2025 | Jan. 15, 2025, 5:23 p.m. |
|
Paravasthu Mukund
Chief Operating Officer
|
Sale | 44 | Nov 02, 2024 | Nov. 6, 2024, 5:27 p.m. |
|
Puri Michal Nath
Chief Human Resources Officer
|
Sale | 810 | Oct 31, 2024 | Nov. 4, 2024, 5:34 p.m. |
|
Leonard Frank X
EVP, Pres., Novocure Oncology
|
Sale | 598 | Nov 01, 2024 | Nov. 4, 2024, 5:34 p.m. |
|
Paravasthu Mukund
Chief Operating Officer
|
Sale | 160 | Nov 01, 2024 | Nov. 4, 2024, 5:32 p.m. |
|
Cordova Ashley
Chief Financial Officer
|
Sale | 688 | Aug 02, 2024 | Aug. 5, 2024, 4:25 p.m. |
|
VERNON W ANTHONY
|
Sale | 964 | Jun 04, 2024 | June 6, 2024, 5:43 p.m. |
|
Scannell Timothy J
|
Sale | 964 | Jun 04, 2024 | June 6, 2024, 5:42 p.m. |
|
LEUNG GABRIEL
|
Sale | 964 | Jun 04, 2024 | June 6, 2024, 5:42 p.m. |
|
GROENHUYSEN WILHELMUS CM
Chief Operating Officer
|
Sale | 2107 | Mar 01, 2024 | March 5, 2024, 5:09 p.m. |
|
GROENHUYSEN WILHELMUS CM
Chief Operating Officer
|
Sale | 1217 | Mar 04, 2024 | March 5, 2024, 5:09 p.m. |
|
Leonard Frank X
EVP, Pres., Novocure Oncology
|
Sale | 840 | Mar 04, 2024 | March 5, 2024, 5:08 p.m. |
|
Leonard Frank X
EVP, Pres., Novocure Oncology
|
Sale | 1679 | Mar 01, 2024 | March 5, 2024, 5:08 p.m. |
|
Leonard Frank X
EVP, Pres., Novocure Oncology
|
Sale | 2078 | Feb 28, 2024 | Feb. 29, 2024, 5:38 p.m. |
|
GROENHUYSEN WILHELMUS CM
Chief Operating Officer
|
Sale | 2303 | Feb 28, 2024 | Feb. 29, 2024, 5:28 p.m. |
|
Shah Pritesh
Chief Growth Officer
|
Sale | 382 | Nov 07, 2023 | Nov. 8, 2023, 5:22 p.m. |
|
Cordova Ashley
Chief Financial Officer
|
Sale | 883 | Sep 01, 2023 | Sept. 5, 2023, 4:24 p.m. |
|
GROENHUYSEN WILHELMUS CM
Chief Operating Officer
|
Sale | 294 | Sep 01, 2023 | Sept. 5, 2023, 4:24 p.m. |
|
Shah Pritesh
Chief Growth Officer
|
Sale | 273 | Sep 01, 2023 | Sept. 5, 2023, 4:23 p.m. |
|
Cordova Ashley
Chief Financial Officer
|
Sale | 1144 | Aug 02, 2023 | Aug. 4, 2023, 4:02 p.m. |
|
Leonard Frank X
President, CNS Cancers US
|
Sale | 4403 | Mar 03, 2023 | March 7, 2023, 5:52 p.m. |
|
Leonard Frank X
President, CNS Cancers US
|
Sale | 6003 | Mar 07, 2023 | March 7, 2023, 5:52 p.m. |
|
Leonard Frank X
President, CNS Cancers US
|
Sale | 888 | Mar 03, 2023 | March 7, 2023, 5:52 p.m. |
|
Leonard Frank X
President, CNS Cancers US
|
Sale | 2315 | Mar 07, 2023 | March 7, 2023, 5:52 p.m. |
|
Shah Pritesh
Chief Growth Officer
|
Sale | 1570 | Mar 03, 2023 | March 7, 2023, 5:52 p.m. |
|
Shah Pritesh
Chief Growth Officer
|
Sale | 2942 | Mar 03, 2023 | March 7, 2023, 5:52 p.m. |
|
Shah Pritesh
Chief Growth Officer
|
Sale | 16909 | Mar 03, 2023 | March 7, 2023, 5:52 p.m. |
|
GROENHUYSEN WILHELMUS CM
Chief Operating Officer
|
Sale | 20415 | Mar 03, 2023 | March 7, 2023, 5:51 p.m. |
|
GROENHUYSEN WILHELMUS CM
Chief Operating Officer
|
Sale | 3528 | Mar 03, 2023 | March 7, 2023, 5:51 p.m. |
|
GROENHUYSEN WILHELMUS CM
Chief Operating Officer
|
Sale | 1692 | Mar 03, 2023 | March 7, 2023, 5:51 p.m. |
|
Cordova Ashley
Chief Financial Officer
|
Sale | 4730 | Mar 03, 2023 | March 7, 2023, 5:51 p.m. |
|
Cordova Ashley
Chief Financial Officer
|
Sale | 775 | Mar 03, 2023 | March 7, 2023, 5:51 p.m. |
|
Burke William Patrick
Chief Human Resources Officer
|
Sale | 593 | Mar 03, 2023 | March 7, 2023, 5:50 p.m. |
|
Burke William Patrick
Chief Human Resources Officer
|
Sale | 281 | Mar 02, 2023 | March 6, 2023, 5:42 p.m. |
|
Shah Pritesh
Chief Growth Officer
|
Sale | 937 | Mar 02, 2023 | March 6, 2023, 5:41 p.m. |